These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 2845241

  • 21. Renal tubular defects in recurring bilateral nephrolithiasis.
    D'Angelo A, Pagano F, Ossi E, Lupo A, Valvo E, Messa P, Tessitore N, Maschio G.
    Clin Nephrol; 1976 Aug; 6(2):352-60. PubMed ID: 954242
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [Abstract] [Full Text] [Related]

  • 25. [Evidence for a glucose-dependent renal phosphorus leak in normo- and hypercalciuric stone-formers (author's transl)].
    Aubert J, Ulmann A, Lacour B, Bader C, Funck-Brentano JL.
    Nephrologie; 1980 Jan; 1(4):159-62. PubMed ID: 6895406
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bicarbonate re-absorption in renal stone patients with acidification defects.
    Backman U, Danielson BG, Sohtell M.
    Scand J Urol Nephrol; 1976 Jan; Suppl 35():62-75. PubMed ID: 26970
    [Abstract] [Full Text] [Related]

  • 28. [Exaggerated calciuric response to an acute acid load in patients forming renal calcium stones].
    Normand M, Cayotte JL, Houillier P, Peuchant A, Paillard M.
    Nephrologie; 1993 Jan; 14(6):283-5. PubMed ID: 8145886
    [Abstract] [Full Text] [Related]

  • 29. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO, Wipplinger J.
    Eur J Med Res; 2008 Jul 28; 13(7):332-42. PubMed ID: 18700191
    [Abstract] [Full Text] [Related]

  • 30. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
    Gardin JP, Paillard M.
    Miner Electrolyte Metab; 1984 Jul 28; 10(5):301-8. PubMed ID: 6493158
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Calcium concentrations in the urine of recurrent stone-formers and their controls (author's transl)].
    Leskovar P, Hartung R, Siebert A, Wellnhofer E.
    Urologe A; 1980 Jul 28; 19(4):207-13. PubMed ID: 7414765
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S, Kitagawa M, Morimoto S, Miyazaki Y, Minakata S, Yasukawa S, Fukatani T, Ohkawa T.
    Hinyokika Kiyo; 1985 Jan 28; 31(1):1-15. PubMed ID: 3993484
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S, Dopsaj V, Jovicić S, Milenković D, Jovanović D, Nesić V.
    Med Pregl; 2007 Jan 28; 60 Suppl 2():117-20. PubMed ID: 18928175
    [Abstract] [Full Text] [Related]

  • 38. Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.
    Ritz E, Schmidt-Gayk H, Möhring K.
    Eur Urol; 1975 Jan 28; 1(3):131-3. PubMed ID: 183957
    [Abstract] [Full Text] [Related]

  • 39. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P, Prunet D.
    Prog Urol; 2006 Nov 28; 16(5):542-5. PubMed ID: 17175947
    [Abstract] [Full Text] [Related]

  • 40. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH, Coe FL, Evan AP, Worcester EM.
    BJU Int; 2009 Mar 28; 103(5):670-8. PubMed ID: 18793297
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.